申请人:ONO PHARMACEUTICAL CO., LTD.
公开号:EP1666468A1
公开(公告)日:2006-06-07
CRF antagonists comprising as an active ingredient, the compound of formula (I)
wherein A ring is 5-6 membered mono-cyclic ring which may be substituted; B ring is 5-7 membered unsaturated mono-heterocyclic ring which may be contained another 1-2 of hetero atom(s) and substituted by another substituents; W1 and W2 is carbon atom or nitrogen atom; Z is NR3, oxygen atom, sulfur which may be oxidized or CR4R5; R' is alkyl, alkenyl or alkynyl that may be substituted, amino which may be protected, hydroxyl which may be protected, S(O)nR6, COR7, or cyclic group which may be substituted; R2 is unsaturated cyclic group which may be substituted.
CRF 拮抗剂,其活性成分包括式(I)化合物
其中 A 环为 5-6 个成员的单环,可被取代;B 环为 5-7 个成员的不饱和单杂环,可含有 1-2 个杂原子并被其他取代基取代;W1 和 W2 为碳原子或氮原子;Z 是 NR3、氧原子、可被氧化的硫或 CR4R5;R'是可被取代的烷基、烯基或炔基、可被保护的氨基、可被保护的羟基、S(O)nR6、COR7 或可被取代的环基;R2 是可被取代的不饱和环基。